Germany's Direvo Biotech, a protein engineering company, has raised $16.8 million in its third round. Part of that money is being earmarked for its collaboration and research programs in therapeutic proteases and antibodies. A big group of investors participated in the round, including Danisco Venture A/S, Copenhagen, S-Equity Partner, Cologne, Mulligan BioCapital, Hamburg and funds managed by New York based Signet Healthcare Partners, as well as private investors such as Nobel laureate Prof. Manfred Eigen.
- see this release [1] for more info
ALSO: Ikonisys has raised $30 million to advance its work in diagnostics. Release [2]
Read more on: Venture capital news [3]
Links:
[1] http://www.fiercebiotech.com/press-releases/press-release-direvo-raises-euro-12-million-usd-16-8-million-series-c-financing
[2] http://www.fiercebiotech.com/press-releases/press-release-ikonisys-closes-30-million-series-e-financing
[3] http://www.fiercebiotech.com/tags/venture-capitalists